Matches in Wikidata for { <http://www.wikidata.org/entity/Q37603669> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- Q37603669 description "2017 ജനുവരി 18 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q37603669 description "article científic" @default.
- Q37603669 description "article scientifique" @default.
- Q37603669 description "articolo scientifico" @default.
- Q37603669 description "artigo científico" @default.
- Q37603669 description "artículu científicu espublizáu en 2017" @default.
- Q37603669 description "bilimsel makale" @default.
- Q37603669 description "scientific article published on 18 January 2017" @default.
- Q37603669 description "vedecký článok" @default.
- Q37603669 description "vetenskaplig artikel" @default.
- Q37603669 description "videnskabelig artikel" @default.
- Q37603669 description "vědecký článek" @default.
- Q37603669 description "wetenschappelijk artikel" @default.
- Q37603669 description "wissenschaftlicher Artikel" @default.
- Q37603669 description "наукова стаття, опублікована в січні 2017" @default.
- Q37603669 description "научни чланак" @default.
- Q37603669 description "مقالة علمية نشرت في 18 يناير 2017" @default.
- Q37603669 name "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 name "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 name "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 type Item @default.
- Q37603669 label "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 label "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 label "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 prefLabel "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 prefLabel "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 prefLabel "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 P1433 Q37603669-4447BAB1-2E36-404E-8CF3-46FD782B7DC2 @default.
- Q37603669 P1476 Q37603669-F833C548-01FD-4F93-BFAA-FC92C7359051 @default.
- Q37603669 P2093 Q37603669-1BF6B98F-5D3F-4E70-B61D-D4B9F424F6BB @default.
- Q37603669 P2093 Q37603669-A373A61F-EF4F-4830-8261-21AABF20303E @default.
- Q37603669 P2093 Q37603669-D186E31B-5F65-4EF2-8F6C-8F17BFB0306D @default.
- Q37603669 P2093 Q37603669-D384FB06-86F9-4079-AC89-2948E34C84E2 @default.
- Q37603669 P275 Q37603669-3c5a9f32-b215-4621-a4b2-500b80ae16ab @default.
- Q37603669 P2860 Q37603669-0D63C910-74DD-4C70-955D-73367334B6E0 @default.
- Q37603669 P2860 Q37603669-20764D94-6343-4B02-B6A1-C0880ED5EEA8 @default.
- Q37603669 P2860 Q37603669-219357EE-477A-4D2A-9D82-164274364829 @default.
- Q37603669 P2860 Q37603669-3F79F2FC-E418-4B9C-A719-C191E470CF00 @default.
- Q37603669 P2860 Q37603669-4A47C4C6-71D2-4B89-B22F-62133F98543B @default.
- Q37603669 P2860 Q37603669-763DFF2D-2DA2-4330-BD6F-DFA61148B618 @default.
- Q37603669 P2860 Q37603669-8D9B2504-279C-4CA9-B506-A9F66540A389 @default.
- Q37603669 P2860 Q37603669-9A5DBB18-07D5-4235-B84F-0B4159DE9979 @default.
- Q37603669 P2860 Q37603669-A2A17FF1-CE69-4A46-8DB4-DFB0FC98CD29 @default.
- Q37603669 P2860 Q37603669-A3E13BEC-5A99-49C3-A0FF-D9B490E9B718 @default.
- Q37603669 P2860 Q37603669-AE87368A-C611-49E8-9BA3-76DC4748F6D5 @default.
- Q37603669 P2860 Q37603669-BB340510-36A6-44FB-BCD5-090F0858D875 @default.
- Q37603669 P2860 Q37603669-C6C561F6-901D-46C2-9B30-FF54FEF4E004 @default.
- Q37603669 P2860 Q37603669-DEC5B4BA-9313-424F-B9F4-3EFCB44AAB02 @default.
- Q37603669 P2860 Q37603669-E336C90B-DC1F-4BA8-9A22-C8FBB170C26D @default.
- Q37603669 P2860 Q37603669-F1285BF7-24D5-4161-B663-BAA86BEF44EF @default.
- Q37603669 P2860 Q37603669-FD040306-68FC-4D38-98BE-7B27DA95B76A @default.
- Q37603669 P2860 Q37603669-FE263E7F-FE30-4823-84DA-C7634A522512 @default.
- Q37603669 P304 Q37603669-4A7C4140-AE07-4AE8-A52C-A2393619DCBC @default.
- Q37603669 P31 Q37603669-C9FF5DED-5D2D-4AC4-B4F2-74B71A57A293 @default.
- Q37603669 P356 Q37603669-A95A8E26-3819-4379-B4B0-E173E11641E0 @default.
- Q37603669 P407 Q37603669-24025BCA-3D30-4194-8709-49B64FA8B0E3 @default.
- Q37603669 P478 Q37603669-1A9904EA-57E5-403B-A2AC-21AD5DFF9565 @default.
- Q37603669 P577 Q37603669-BA18B015-924F-4F5C-BA68-8E0502C801DD @default.
- Q37603669 P6216 Q37603669-7daf989a-a1cd-44ce-bcac-57b33565ad41 @default.
- Q37603669 P698 Q37603669-CBFD6C7B-B107-4EEC-8CD2-A17C3102F6BC @default.
- Q37603669 P921 Q37603669-30114EF0-BED7-4D1C-A100-8B266703E1BB @default.
- Q37603669 P932 Q37603669-71393E80-2E96-4C6E-A25C-79B51C1963DE @default.
- Q37603669 P356 OTT.S126613 @default.
- Q37603669 P698 28176910 @default.
- Q37603669 P1433 Q7092081 @default.
- Q37603669 P1476 "Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma" @default.
- Q37603669 P2093 "Hai-Tao Zhang" @default.
- Q37603669 P2093 "Shen-Cun Fang" @default.
- Q37603669 P2093 "Wei-Ping Xie" @default.
- Q37603669 P2093 "Ying-Ming Zhang" @default.
- Q37603669 P275 Q18810331 @default.
- Q37603669 P2860 Q24617999 @default.
- Q37603669 P2860 Q26745516 @default.
- Q37603669 P2860 Q26748851 @default.
- Q37603669 P2860 Q28072496 @default.
- Q37603669 P2860 Q28278736 @default.
- Q37603669 P2860 Q29547625 @default.
- Q37603669 P2860 Q33413742 @default.
- Q37603669 P2860 Q33710574 @default.
- Q37603669 P2860 Q34547495 @default.
- Q37603669 P2860 Q34662482 @default.
- Q37603669 P2860 Q35978881 @default.
- Q37603669 P2860 Q37644847 @default.
- Q37603669 P2860 Q38107552 @default.
- Q37603669 P2860 Q39991776 @default.
- Q37603669 P2860 Q53507853 @default.
- Q37603669 P2860 Q54048009 @default.
- Q37603669 P2860 Q59565902 @default.
- Q37603669 P2860 Q95375604 @default.
- Q37603669 P304 "447-452" @default.
- Q37603669 P31 Q13442814 @default.
- Q37603669 P356 "10.2147/OTT.S126613" @default.
- Q37603669 P407 Q1860 @default.
- Q37603669 P478 "10" @default.
- Q37603669 P577 "2017-01-18T00:00:00Z" @default.
- Q37603669 P6216 Q50423863 @default.
- Q37603669 P698 "28176910" @default.
- Q37603669 P921 Q356033 @default.
- Q37603669 P932 "5261838" @default.